Aldeyra Therapeutics, Inc.
(NASDAQ : ALDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.41%430.050.0%$6120.58m
BNTXBioNTech SE -3.62%359.180.0%$1251.77m
NVAXNovavax, Inc. 0.11%237.5479.4%$944.01m
SNSSSunesis Pharmaceuticals, Inc. 2.23%8.710.7%$608.86m
AMGNAmgen, Inc. 0.93%219.381.4%$559.38m
REGNRegeneron Pharmaceuticals, Inc. -0.20%651.882.7%$494.43m
GILDGilead Sciences, Inc. 0.39%71.611.0%$434.34m
ILMNIllumina, Inc. -0.65%447.013.5%$405.38m
TECHBio-Techne Corp. 0.92%534.354.5%$355.95m
BIIBBiogen, Inc. 0.17%300.191.7%$306.30m
VRTXVertex Pharmaceuticals, Inc. 0.64%188.301.9%$241.59m
ISEEIVERIC bio, Inc. 1.59%16.620.0%$194.78m
BGNEBeiGene Ltd. 4.65%403.141.3%$186.17m
LIFEaTyr Pharma, Inc. 0.49%10.313.2%$144.19m
EXASEXACT Sciences Corp. 5.22%108.1518.1%$135.69m

Company Profile

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.